Amdocs Limited
DOX · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -3.63 | 16.44 | -1.05 | 0.32 |
| FCF Yield | 6.24% | 7.02% | 5.51% | 7.43% |
| EV / EBITDA | 12.64 | 11.96 | 11.09 | 9.38 |
| Quality | ||||
| ROIC | 10.65% | 10.92% | 10.87% | 9.61% |
| Gross Margin | 35.07% | 35.35% | 35.38% | 34.46% |
| Cash Conversion Ratio | 1.32 | 1.46 | 1.52 | 1.38 |
| Growth | ||||
| Revenue 3-Year CAGR | -2.48% | 3.03% | 4.45% | 3.16% |
| Free Cash Flow Growth | -11.36% | 31.87% | -25.98% | 58.05% |
| Safety | ||||
| Net Debt / EBITDA | 0.54 | 0.34 | 0.28 | 0.16 |
| Interest Coverage | 18.02 | 28.32 | 39.31 | 28.14 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 40.63 | 36.65 | 58.92 | 58.04 |